Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
men decrease » mean decrease (Expand Search), we decrease (Expand Search), meja decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 men » 10 min (Expand Search), 10 women (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
men decrease » mean decrease (Expand Search), we decrease (Expand Search), meja decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 men » 10 min (Expand Search), 10 women (Expand Search)
-
641
-
642
A model for MEN regulation by PP2A<sup>Cdc55</sup>.
Published 2013“…<p>In early anaphase, FEAR-induced inactivation of the PP2A<sup>Cdc55</sup> promotes the first wave of Cdc14 release and contributes to the accumulation of the Cdc5-phosphorylated form of Bfa1. …”
-
643
-
644
-
645
-
646
-
647
A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization-5
Published 2011“…<p><b>Copyright information:</b></p><p>Taken from "A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization"</p><p>BMC Cardiovascular Disorders 2007;7():4-4.…”
-
648
Inhibition of RET reduces phosphorylation of DNA-PKcs s2056 and blocking DNA-PKcs activity increases chemosensitivity.
Published 2015“…<p>A) TT cells were treated with RPI-1 (5 μM) to inhibit RET for 24 hrs prior to nuclei isolation. …”
-
649
Flow chart of the study procedures.
Published 2023“…The median RPR titer ratio at treatment initiation/diagnosis was 0.87 (IQR, 0.48–1.30). The RPR titer decreased more than twofold in 26.5% (18/68) and more than fourfold in 10.3% (7/68) before treatment. …”
-
650
-
651
-
652
-
653
-
654
-
655
-
656
-
657
Inhibition of IL-17A at tumor sites decreases the intratumoral microvessel density.
Published 2013“…<p>(A) The endothelial maker CD31-stained sections of tumor tissue are shown in Ad-SNC and Ad-si-IL-17 treatment models, Ad-si-IL-17 treatment decreased the intratumoral microvessel density compared with Ad-SNC. …”
-
658
-
659
-
660